Eribulin — a welcomed advance
نویسندگان
چکیده
منابع مشابه
most welcomed Economics & Corporate Culture ∗
Most non-economists would question whether economists know anything about culture. Indeed, given some faculty meetings I’ve been through, I imagine they might go so far as to say economists are uncultured. Although the second sentiment probably does go too far, there is certainly merit to the first. In particular, with a few exceptions (notably Kreps, 1990; Crémer, 1993; Lazear, 1995; Hodgson, ...
متن کاملEribulin in Cancer Treatment
Halichondrin B is a complex, natural, polyether macrolide derived from marine sponges. Eribulin is a structurally-simplified, synthetic, macrocyclic ketone analogue of Halichondrin B. Eribulin was approved by United States Food and Drug Administration in 2010 as a third-line therapy for metastatic breast cancer patients who have previously been treated with an anthracycline and a taxane. It has...
متن کاملShould Speculators Be Welcomed in Auctions?
The possibility of resale after an auction attracts speculators (i.e., bidders who have no use value for the objects on sale). In a multi-object auction, a high-value bidder may strictly prefer to let a speculator win some of the objects and then buy in the resale market, in order to keep the auction price low for the objects she wins in the auction. Therefore, although speculators increase com...
متن کاملProfit - Welcomed or Disdained by Ancient Romans ?
"Salve Lucrum," an inscription embedded in the threshold of Casa di Sirico, a large mansion in Pompeii, raises an interesting question. "Salve" is a term used by the Romans as a greeting; thus the phrase can be translated as "Hail Profit!" This greeting can be contrasted to the view, suggested by some contemporaneous literature, that the Roman elite distanced themselves from commercial activity...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2016
ISSN: 1759-4774,1759-4782
DOI: 10.1038/nrclinonc.2016.33